[go: up one dir, main page]

WO2012016030A3 - Détection d'une inflammation - Google Patents

Détection d'une inflammation Download PDF

Info

Publication number
WO2012016030A3
WO2012016030A3 PCT/US2011/045705 US2011045705W WO2012016030A3 WO 2012016030 A3 WO2012016030 A3 WO 2012016030A3 US 2011045705 W US2011045705 W US 2011045705W WO 2012016030 A3 WO2012016030 A3 WO 2012016030A3
Authority
WO
WIPO (PCT)
Prior art keywords
inflammation detection
inflammation
detection
genes
reagents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2011/045705
Other languages
English (en)
Other versions
WO2012016030A2 (fr
Inventor
Stephen F. Lowry
Beatrice Haimovich
Michael Reddell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rutgers State University of New Jersey
Rutgers Health
Original Assignee
University of Medicine and Dentistry of New Jersey
Rutgers State University of New Jersey
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Medicine and Dentistry of New Jersey, Rutgers State University of New Jersey filed Critical University of Medicine and Dentistry of New Jersey
Publication of WO2012016030A2 publication Critical patent/WO2012016030A2/fr
Publication of WO2012016030A3 publication Critical patent/WO2012016030A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La présente invention concerne des procédés et des réactifs de détection et de surveillance d'une inflammation et d'une lésion chez un sujet par détermination des niveaux d'expression de groupes de gènes.
PCT/US2011/045705 2010-07-28 2011-07-28 Détection d'une inflammation Ceased WO2012016030A2 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US36853210P 2010-07-28 2010-07-28
US61/368,532 2010-07-28
US201161432387P 2011-01-13 2011-01-13
US61/432,387 2011-01-13

Publications (2)

Publication Number Publication Date
WO2012016030A2 WO2012016030A2 (fr) 2012-02-02
WO2012016030A3 true WO2012016030A3 (fr) 2012-05-10

Family

ID=45530717

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2011/045705 Ceased WO2012016030A2 (fr) 2010-07-28 2011-07-28 Détection d'une inflammation

Country Status (1)

Country Link
WO (1) WO2012016030A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102014112924A1 (de) 2014-09-09 2016-03-10 Friedrich-Alexander-Universität Erlangen-Nürnberg Verfahren und System zur Detektion von Krankheitsbildern
DE102014112923A1 (de) 2014-09-09 2016-03-10 Friedrich-Alexander-Universität Erlangen-Nürnberg Verfahren und System zur Detektion von Krankheitsbildern
GB201616557D0 (en) * 2016-09-29 2016-11-16 Secretary Of State For Health The Assay for distinguishing between sepsis and systemic inflammatory response syndrome

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060003335A1 (en) * 2004-06-30 2006-01-05 Crispino John D Methods for diagnosing acute megakaryoblastic leukemia
US20060216707A1 (en) * 2002-07-24 2006-09-28 Bruno Stuhlmuller Nucleic acid array consisting of selective monocyte macrophage genes
US20070048301A1 (en) * 2002-11-26 2007-03-01 Bodary-Winter Sarah C Compositions and methods for the treatment of immune related diseases
US20090186034A1 (en) * 2006-12-19 2009-07-23 Genetech, Inc. Gene expression markers for inflammatory bowel disease
US20090203534A1 (en) * 2005-10-21 2009-08-13 Hamid Hossain Expression profiles for predicting septic conditions
US20090304703A1 (en) * 1999-09-24 2009-12-10 Millennium Pharmaceuticals, Inc. Compositions and methods for the diagnosis and treatment of immune disorders

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090304703A1 (en) * 1999-09-24 2009-12-10 Millennium Pharmaceuticals, Inc. Compositions and methods for the diagnosis and treatment of immune disorders
US20060216707A1 (en) * 2002-07-24 2006-09-28 Bruno Stuhlmuller Nucleic acid array consisting of selective monocyte macrophage genes
US20070048301A1 (en) * 2002-11-26 2007-03-01 Bodary-Winter Sarah C Compositions and methods for the treatment of immune related diseases
US20060003335A1 (en) * 2004-06-30 2006-01-05 Crispino John D Methods for diagnosing acute megakaryoblastic leukemia
US20090203534A1 (en) * 2005-10-21 2009-08-13 Hamid Hossain Expression profiles for predicting septic conditions
US20090186034A1 (en) * 2006-12-19 2009-07-23 Genetech, Inc. Gene expression markers for inflammatory bowel disease

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
HAIMOVICH ET AL.: "In vivo endotoxin synchronizes and suppresses clock gene expression in human peripheral blood leukocytes.", CRIT. CARE MED., vol. 38, no. 3, March 2010 (2010-03-01), pages 751 - 758 *

Also Published As

Publication number Publication date
WO2012016030A2 (fr) 2012-02-02

Similar Documents

Publication Publication Date Title
WO2011150115A3 (fr) Méthodes et appareil de détection délocalisée d'acide nucléique dans un échantillon
WO2013030578A3 (fr) Procédé de détection de nucléosomes
EP2759981A4 (fr) Procédé de détection de rides, dispositif de détection de rides et programme de détection de rides ainsi que procédé d'évaluation de rides, dispositif d'évaluation de rides et programme d'évaluation de rides
WO2011087897A3 (fr) Dispositif de détection d'oestrus
EP2430428A4 (fr) Système et procédés de détection de molécules individuelles
IL224361A (en) A method for optimally determining the characteristics and arrangement of an area monitoring sensor kit
IL234385B (en) Methods and compositions for detecting multiple analytes with a single signal
IL211297A (en) Device and method for locating a position indicator
WO2013084154A3 (fr) Procédé et appareil pour la détection d'un mouvement d'ascenseur
GB201002627D0 (en) Aptamer based analyte detection method
WO2011104517A3 (fr) Détection de capacitance en analyse électrochimique
EP2823402A4 (fr) Procédés de détermination de paramètres de détection et de mémoire
FR2962222B1 (fr) Procede de detection d'interactions moleculaires
WO2012012694A3 (fr) Procédés de détection de maladies/pathologies auto-immunes ou liées au système immunitaire
WO2012012709A3 (fr) Méthodes de détection de maladies ou de pathologies cardiovasculaires
GB201113907D0 (en) Signal evaluation system and method
PL2563932T3 (pl) Wykrywanie komórek odpornościowych, w szczególności komórek T poprzez analizę metylacji DNA genów CCR6
WO2012141521A3 (fr) Appareil pour détecter une pression de vent bidirectionnelle
EP2612910A4 (fr) Procédé pour détecter une substance cible, ensemble d'aptamères utilisé pour celui-ci, capteur, et dispositif
SG11201401345RA (en) Methods of detecting the presence of microorganisms in a sample
EP2865764A4 (fr) Procédé de détection d'un acide nucléique et kit de détection afférent
IL229741A0 (en) Sensor device, manufacturing method and detection device
EP2798078A4 (fr) Procédé et ensemble d'amorces pour détecter une mutation
WO2012016030A3 (fr) Détection d'une inflammation
GB201203545D0 (en) Impact detection and monitoring system

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11813176

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11813176

Country of ref document: EP

Kind code of ref document: A2